# Mesenchymal Stem Cells Treatment for AIDS Patients at Late Stage

> **NCT05939167** · PHASE1,PHASE2 · RECRUITING · sponsor: **Cell Energy Life Sciences Group Co. LTD** · enrollment: 150 (estimated)

## Conditions studied

- AIDS

## Interventions

- **DRUG:** mesenchymal stem cell
- **OTHER:** saline

## Key facts

- **NCT ID:** NCT05939167
- **Lead sponsor:** Cell Energy Life Sciences Group Co. LTD
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-10
- **Primary completion:** 2027-07-10
- **Final completion:** 2028-07-10
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-08-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05939167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05939167, "Mesenchymal Stem Cells Treatment for AIDS Patients at Late Stage". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05939167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*